Journal of Adolescent Health
Volume 35, Issue 1 , Pages 66-70 , July 2004

Provision of emergency contraception to adolescents: Position paper of the society for adolescent medicine

References 

  1. Alan Guttmacher Institute . U.S. Teenage Pregnancy Statistics (Overall Trends, Trends by Race and Ethnicity and State-by-State Information). New York, NY: Alan Guttmacher Institute; 2004;
  2. Trussell J, Ellertson C, von Hertzen H, et al.  Estimating the effectiveness of emergency contraceptive pills. Contraception. 2003;67:259–265
  3. Trussell J, Rodriguez G, Ellertson C. Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception. 1999;59:147–151
  4. von Hertzen H, Piaggio G, Ding J, et al.  WHO Research Group on Post-ovulatory Methods of Fertility Regulation. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception (a WHO multicentre randomised trial). Lancet. 2002;360:1803–1810
  5. Trussell J, Stewart F, Guest F, Harcher RA. Emergency contraceptive pills (a simple proposal to reduce unintended pregnancies). Fam Plann Perspect. 1992;24:269–273
  6. Task Force on Postovulatory Methods of Fertility Regulation . Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet. 1998;352:428–433
  7. Ellertson C, Evans M, Ferden S, et al.  Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours. Obstet Gynecol. 2003;101:1168–1171
  8. Rodrigues I, Grou F, Joly J. Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse. Am J Obstet Gynecol. 2001;184:531–537
  9. Piaggio G, von Hertzen H, Grimes DA, Van Look PF. Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Task Force on Postovulatory Methods of Fertility Regulation. Lancet. 1999;353:721
  10. Croxatto HB, Ortiz ME, Muller AL. Mechanisms of action of emergency contraception. Steroids. 2003;68:1095–1098
  11. Bracken MB. Oral contraceptives and congenital malformations in offspring (A review and meta-analysis of the prospective studies). Obstet Gynecol. 1990;76:552–557
  12. Simpson JL, Phillips OP. Spermicides, hormonal contraception and congenital malformations. Adv Contracept. 1990;6:141–167
  13. American College of Obstetricians and Gynecologists . Contraceptives and congenital anomalies. Int J Gynaecol Obstet. 1993;42:316–317
  14. Webb A, Taberner D. Clotting factors after emergency contraception. Adv Contracept. 1993;9:75–82
  15. Vasilakis C, Jick H, del Mar Melero-Montes M. Risk of idiopathic venous thromboembolism in users of progestagens alone. Lancet. 1999;354:1610–1611
  16. Bennett W, Petraitis C, D'Anella A, Marcella S. Pharmacists' knowledge and the difficulty of obtaining emergency contraception. Contraception. 2003;68:261–267
  17. Drazen JM, Green MF, Wood AJJ. The FDA, politics and Plan B. N Engl J Med. 2004;350:1561–1562
  18. Gold MA, Schein A, Coupey SM. Emergency contraception (A national survey of adolescent health experts). Fam Plann Perspect. 1997;29:15–19
  19. Sills MR, Chamberlain JM, Teach SJ. The associations among pediatricians' knowledge, attitudes, and practices regarding emergency contraception. Pediatrics. 2000;105:954–956
  20. Golden NH, Seigel WM, Fisher M, et al.  Emergency contraception (pediatricians' knowledge, attitudes, and opinions). Pediatrics. 2001;107:287–292

PII: S1054-139X(04)00120-X

doi: 10.1016/j.jadohealth.2004.04.005

Journal of Adolescent Health
Volume 35, Issue 1 , Pages 66-70 , July 2004

Article Tools